By-health Co., Ltd.

SZSE:300146.SZ

17.73 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 9,313.7097,861.4127,431.2786,094.9015,261.7994,350.7763,110.7952,309.1122,266.0431,704.9811,482.2421,066.692657.964346.081205.29141.85766.85
Cost of Revenue 3,083.6922,493.3152,521.8282,266.3581,800.6981,406.9221,024.145822.073764.211580.009523.274390.701235.821122.9775.52856.32730.794
Gross Profit 6,230.0165,368.0974,909.453,828.5423,461.1022,943.8542,086.651,487.0391,501.8321,124.972958.968675.991422.143223.111129.76285.53136.056
Gross Profit Ratio 0.6690.6830.6610.6280.6580.6770.6710.6440.6630.660.6470.6340.6420.6450.6320.6030.539
Reseach & Development Expenses 169.37158.497150.299139.952126.041103.4977.26495.84586.03652.79844.22919.7636.8142.537000
General & Administrative Expenses 132.40668.96481.436109.598110.992123.4483.17545.46329.80946.01741.51724.33718.68910.49620.23318.1058.033
Selling & Marketing Expenses 3,859.0793,169.2492,478.441,818.4191,650.41,280.078973.267638.851618.609397.041317.017265.891180.85585.79345.80329.75810.832
SG&A 4,207.4443,238.2122,559.8761,928.0171,761.3921,403.5181,056.442684.314648.417443.058358.534290.229199.54496.28966.03647.86318.865
Other Expenses 0.775374.011346.364386.437320.07526.396.64525.0119.66139.0965.6283.1582.6040.4610.372-0.4-0.162
Operating Expenses 4,376.0393,770.723,056.5392,454.4062,207.5081,754.4461,287.797884.768839.282577.89473.803366.985239.578116.75868.10149.11718.959
Operating Income 1,853.9771,609.2992,026.7841,788.721,346.4231,102.597878.359635.83720.834554.107502.793331.727217.421107.45461.36834.94917.869
Operating Income Ratio 0.1990.2050.2730.2930.2560.2530.2820.2750.3180.3250.3390.3110.330.310.2990.2460.267
Total Other Income Expenses Net 384.63795.49151.218-20.034-1,771.291-60.42186.15151.44477.40945.15518.04522.19837.3611.549-0.307-1.949-1.417
Income Before Tax 2,238.6141,704.7892,178.0021,768.686-424.8681,128.987885.004653.716739.959592.237503.209331.203219.925107.90161.35534.46515.68
Income Before Tax Ratio 0.240.2170.2930.29-0.0810.2590.2840.2830.3270.3470.3390.310.3340.3120.2990.2430.235
Income Tax Expense 417.179293.525411.699224.59-9.823220.555118.198146.061119.61889.64281.52350.84933.4915.7959.1837.763.554
Net Income 1,746.311,385.8511,753.9791,524.251-415.0461,002.185766.256535.212635.496502.595421.686280.354186.43592.10652.17226.70512.126
Net Income Ratio 0.1870.1760.2360.25-0.0790.230.2460.2320.280.2950.2840.2630.2830.2660.2540.1880.181
EPS 1.030.821.030.96-0.280.690.520.370.440.390.320.210.140.0930.060.0370.39
EPS Diluted 1.030.821.030.96-0.280.690.520.370.440.380.320.210.140.0930.060.0370.39
EBITDA 2,098.4022,165.4442,410.3261,751.9211,595.4171,449.9161,076.02797.491747.88628.445543.766369.406229.103113.35764.31135.61718.924
EBITDA Ratio 0.2250.2750.3240.2870.3030.3330.3460.3450.330.3690.3670.3460.3480.3280.3130.2510.283